TeleClinic, Germany’s leading telemedicine platform and a subsidiary of DocMorris, has agreed to acquire Medi24, a leading Swiss telemedicine provider, from Allianz Partners for an enterprise value in the low double-digit CHF million range.
Medi24, which has a team of around 250 doctors, nurses and service staff, has partnerships with the country’s largest health insurers. It offers contractually guaranteed first-line telemedical access to more than 4.6 million insured people, around 50% of all insured persons in Switzerland.
The deal marks TeleClinic’s entry into the Swiss market and the first step in rolling out its core telemedicine technology to other European countries. For DocMorris, it is a building block in scaling its Digital Services division. The purchase will be financed from own funds, debt and equity.
Based on the 2026 financial year, Medi24’s revenue contribution would almost double TeleClinic’s expected revenue. DocMorris expects the acquisition to make a substantial contribution to TeleClinic’s EBITDA in the first year, driven by cost synergies from integrating TeleClinic’s technology into Medi24’s infrastructure.
TeleClinic and Medi24 will continue to operate independently in their home markets to comply with the respective national legal frameworks.
“By contributing our technological expertise and innovative strength, we are systematically expanding the range of digital health services for the benefit of patients in Switzerland and making it easier for them to access simple care,” said Walter Hess, CEO of DocMorris.
Closing is expected in December 2026.
CMS Switzerland advised DocMorris on all legal matters, with a team led by Stefan Brunnschweiler and Andrea Relly.
DocMorris acquired TeleClinic in 2020.
Press release: CMS advises DocMorris on the acquisition of Medi24